藥品名稱
drug name | Dexamethasone 4mg/2ml/amp (Decan)特佳注射液 |
| 藥檔狀態 | 使用中 |
成 份
Ingredient | Dexamethasone |
| 單位含量 | 2 mg/mL, 2 mL/amp |
| Dosage Forms | 2 mg/mL, 2 mL/amp |
| 顏 色 | |
| Color | |
| 形 狀 | |
| Shape | |
| 劑 型 | 針劑/注射 |
| Dose Form | |
大 小
Size | |
標 示
outward | |
廠商名稱
Manufacturer | 永信藥品工業股份有限公司 |
製 造 商
Manufacturer | 永信藥品工業股份有限公司台中幼獅廠 |
字 號
Product ID | 衛署藥製字第011477號 |
藥理分類
Pharmacologic Category | Endocrine and Metabolic/ Adrenocortical Steroids/ Glucocorticosteroids |
作用機轉
Mechanism of action | Decreases inflammation by suppression of neutrophil migration, decreased production of inflammatory mediators, and reversal of increased capillary permeability; suppresses normal immune response. Dexamethasone`s mechanism of antiemetic activity is unknown. |
| 用途/適應症 | 緩解發炎及過敏症狀，治療免疫失調相關疾病 |
| Use |
減少發炎、過敏反應
|
衛福部核准適用症狀
MOHW approved indications |
急、慢性風濕、風濕性關節炎、急性痛風性關節炎、肌炎、皮膚炎、濕疹、癬症、過敏性皮膚炎、炎症性眼疾。
|
| 常用劑量 | 每天一次，早飯後使用4mg
(藥品劑量會因人或病情增減，請依照醫師指示服用。) |
| Dose |
Adult:
Anti-inflammatory:
Oral, I.M., I.V.: 0.75-9 mg/day in divided doses every 6-12 hours
Intra-articular, intralesional, or soft tissue: 0.4-6 mg/day
Extubation or airway edema: Oral, I.M., I.V.: 0.5-2 mg/kg/day in divided doses every 6 hours beginning 24 hours prior to extubation and continuing for 4-6 doses afterwards
Antiemetic:
Prophylaxis: Oral, I.V.: 10-20 mg 15-30 minutes before treatment on each treatment day
Continuous infusion regimen: Oral or I.V.: 10 mg every 12 hours on each treatment day
Mildly emetogenic therapy: Oral, I.M., I.V.: 4 mg every 4-6 hours
Multiple myeloma: Oral, I.V.: 40 mg/day, days 1 to 4, 9 to 12, and 17 to 20, repeated every 4 weeks (alone or as part of a regimen)
Cerebral edema: I.V. 10 mg stat, 4 mg I.M./I.V. (should be given as sodium phosphate) every 6 hours until response is maximized, then switch to oral regimen, then taper off if appropriate; dosage may be reduced after 2-4 days and gradually discontinued over 5-7 days
Treatment of shock:
Addisonian crisis/shock (eg, adrenal insufficiency/responsive to steroid therapy): I.V.: 4-10 mg as a single dose, which may be repeated if necessary
Unresponsive shock (eg, unresponsive to steroid therapy): I.V.: 1-6 mg/kg as a single I.V. dose or up to 40 mg initially followed by repeat doses every 2-6 hours while shock persists
Physiological replacement: Oral, I.M., I.V. (should be given as sodium phosphate): 0.03-0.15 mg/kg/day or 0.6-0.75 mg/m2/day in divided doses every 6-12 hours
Acute mountain sickness (AMS)/high altitude cerebral edema (HACE) (unlabeled use):
Treatment: Oral, I.M., I.V.:
AMS: 4 mg every 6 hours (Luks, 2010)
HACE: Initial: 8 mg as a single dose; Maintenance: 4 mg every 6 hours until symptoms resolve (Luks, 2010)
Antenatal fetal maturation (unlabeled use): I.M.: 6 mg every 12 hours for a total of 4 doses (ACOG, 2011). Note: Recommended for pregnant women with premature labor (24-34 weeks gestation) who are expected to deliver within 7 days.
|
懷孕分級
Pregnancy Risk Factor |
c
|
| 禁忌症 |
仿單：無。對Dexamethasone或產品中其他成份過敏者不建議使用。
|
| Contraindications |
Hypersensitivity to dexamethasone or any component of the formulation; systemic fungal infections, cerebral malaria
|
| 常見副作用 | 食慾增加 消化不良 坐立不安 |
| Common adverse drug reactions | appetite increase, indigestion, restlessness |
| Adverse Reactions |
Fluid retention, hypertension, stomach discomfort, infection and depression.
|
監測
Monitoring |
Hemoglobin, occult blood loss, serum potassium, glucose, growth in children
|
| 警語與注意事項 | 服藥期間請避免施打疫苗或接觸水痘或麻疹病人；本品不適用於Epidural administration。 |
| Warnings & precautions | Please avoid vaccination or exposure to chickenpox or measles patients,do not oral |
| 針劑溶解條件 |
|
| 針劑稀釋條件 |
通常以生理食鹽水稀釋5倍後，每次0.5mg之量注入皮下。
|
| 針劑不相容性 |
仿單無資料。
|
| 針劑施打條件 |
靜脈、肌肉、關節腔內、軟組織內、皮下注射。
|
| 針劑保存安定性 |
室溫儲存。
|
最近修改日期時間
Updated | 7/19/2019 1:37:25 PM |
|
現用藥品
Available
|
停用藥品
Picture2
|
藥品仿單
Package insert sheet
|
|
二維條碼
QR code
|
|